2021
DOI: 10.1111/acer.14639
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of AMPA receptors (AMPARs) containing transmembrane AMPAR regulatory protein γ‐8 with JNJ‐55511118 shows preclinical efficacy in reducing chronic repetitive alcohol self‐administration

Abstract: Background: A prominent therapeutic indication for alcohol use disorder (AUD) is reduction in chronic repetitive alcohol use. Glutamate α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors (AMPARs) regulate chronic alcohol selfadministration in preclinical models. Recent evidence indicates that the expression and function of AMPARs require the transmembrane AMPAR regulatory protein γ-8 (TARP γ-8). This study evaluated the preclinical efficacy of JNJ-55511118, a novel, selective, high-affinity… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
9
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 67 publications
1
9
0
Order By: Relevance
“…Moreover, lack of significant reductions in operant behavior during the initial onset of responding, or on reinforcer consumption (headpokes), suggests lack of memory deficits. This is consistent with our prior observation that systemic administration of JNJ-5 reduced alcohol self-administration by male, but not female, mice in the absence of motor effects (Hoffman et al 2021). Thus, blocking only the subclass of AMPARs associated with TARP γ-8 may provide therapeutic efficacy in the absence of negative side-effects; however, further work needs to explore the possibility of sexually dimorphic sensitivity to JNJ-5 (Hoffman et al 2021) and the potential nonspecific impact of higher doses in females.…”
Section: Discussionsupporting
confidence: 93%
See 3 more Smart Citations
“…Moreover, lack of significant reductions in operant behavior during the initial onset of responding, or on reinforcer consumption (headpokes), suggests lack of memory deficits. This is consistent with our prior observation that systemic administration of JNJ-5 reduced alcohol self-administration by male, but not female, mice in the absence of motor effects (Hoffman et al 2021). Thus, blocking only the subclass of AMPARs associated with TARP γ-8 may provide therapeutic efficacy in the absence of negative side-effects; however, further work needs to explore the possibility of sexually dimorphic sensitivity to JNJ-5 (Hoffman et al 2021) and the potential nonspecific impact of higher doses in females.…”
Section: Discussionsupporting
confidence: 93%
“…This study is the first to examine TARP γ-8 as a driving force of the reinforcing effects of any drug of abuse via activity within a brain reward pathway and provides further support for the premise that targeting this AMPAR subclass may be a viable strategy for developing medications to treat behavioral pathologies associated with AUD (Hoffman et al 2021) or other neurological conditions (Maher et al 2017).…”
Section: Introductionmentioning
confidence: 62%
See 2 more Smart Citations
“…One of the levers was active, in which a response (active lever press) consequently delivered 0.1 ml of fluid from a 15 rpm Razel syringe pump (Stamford, CT) to the appropriate well over 0.5 s. The fluid delivered was tap water in the 12-h training session and either water (control) or 10% (w/v) alcohol (ethanol) diluted in tap water (alcohol group) in subsequent training and testing sessions. The alternate lever was inactive, only recording the operant response (inactive lever press) without delivery of fluid, used as a measure of “non-discriminative lever pressing” [ 66 ]. The active lever was programmed to a fixed ratio 1 (FR1) schedule for training and its location was counterbalanced between each rat (half of the rats had an active left lever, and the other half had an active right lever).…”
Section: Methodsmentioning
confidence: 99%